Shenzhen Historical Income Statement

002551 Stock   3.38  0.08  2.42%   
Historical analysis of Shenzhen Glory income statement accounts such as Selling General Administrative of 103.2 M, Total Revenue of 1.2 B or Cost Of Revenue of 901.2 M can show how well Shenzhen Glory Medical performed in making a profits. Evaluating Shenzhen Glory income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shenzhen Glory's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Shenzhen Glory Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Glory Medical is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Shenzhen Income Statement Analysis

Shenzhen Glory Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Glory shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Shenzhen Glory Income Statement Chart

At present, Shenzhen Glory's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 103.2 M, whereas Operating Income is projected to grow to (18.9 M).

Total Revenue

Total revenue comprises all receipts Shenzhen Glory Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Cost Of Revenue

Cost of Revenue is found on Shenzhen Glory Medical income statement and represents the costs associated with goods and services Shenzhen Glory provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Shenzhen Glory income statement and is an important metric when analyzing Shenzhen Glory Medical profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.
Most accounts from Shenzhen Glory's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shenzhen Glory Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Shenzhen Glory's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 103.2 M, whereas Operating Income is projected to grow to (18.9 M).
 2021 2022 2023 2024 (projected)
Gross Profit362.9M221.9M197.6M319.4M
Research Development52.4M48.2M40.1M52.2M

Shenzhen Glory income statement Correlations

0.660.720.570.620.490.320.480.560.610.060.490.580.52-0.08-0.02-0.080.190.43-0.18
0.660.730.990.40.290.120.710.870.25-0.530.170.260.47-0.07-0.20.380.050.060.02
0.720.730.650.840.750.590.860.530.790.020.740.80.810.130.03-0.140.040.68-0.35
0.570.990.650.30.20.060.670.870.13-0.60.070.150.4-0.08-0.240.440.02-0.030.07
0.620.40.840.30.970.810.60.170.860.370.960.850.810.180.44-0.41-0.030.88-0.73
0.490.290.750.20.970.920.510.030.80.480.950.780.780.220.48-0.52-0.180.92-0.83
0.320.120.590.060.810.920.31-0.180.660.640.830.670.670.290.44-0.71-0.390.88-0.83
0.480.710.860.670.60.510.310.610.53-0.260.490.520.530.16-0.090.20.210.41-0.1
0.560.870.530.870.170.03-0.180.610.15-0.65-0.010.110.3-0.13-0.340.570.13-0.140.18
0.610.250.790.130.860.80.660.530.150.470.910.970.850.050.24-0.530.070.89-0.53
0.06-0.530.02-0.60.370.480.64-0.26-0.650.470.520.470.230.00.45-0.95-0.080.66-0.53
0.490.170.740.070.960.950.830.49-0.010.910.520.890.810.190.4-0.55-0.080.97-0.76
0.580.260.80.150.850.780.670.520.110.970.470.890.880.010.2-0.570.10.89-0.46
0.520.470.810.40.810.780.670.530.30.850.230.810.88-0.120.09-0.43-0.120.79-0.56
-0.08-0.070.13-0.080.180.220.290.16-0.130.050.00.190.01-0.120.140.1-0.490.18-0.21
-0.02-0.20.03-0.240.440.480.44-0.09-0.340.240.450.40.20.090.14-0.390.10.31-0.54
-0.080.38-0.140.44-0.41-0.52-0.710.20.57-0.53-0.95-0.55-0.57-0.430.1-0.390.15-0.710.53
0.190.050.040.02-0.03-0.18-0.390.210.130.07-0.08-0.080.1-0.12-0.490.10.15-0.160.5
0.430.060.68-0.030.880.920.880.41-0.140.890.660.970.890.790.180.31-0.71-0.16-0.74
-0.180.02-0.350.07-0.73-0.83-0.83-0.10.18-0.53-0.53-0.76-0.46-0.56-0.21-0.540.530.5-0.74
Click cells to compare fundamentals

Shenzhen Glory Account Relationship Matchups

Shenzhen Glory income statement Accounts

201920202021202220232024 (projected)
Interest Expense12.1M17.0M7.2M4.4M2.0M3.5M
Selling General Administrative96.4M246.3M115.0M64.9M54.1M103.2M
Total Revenue1.5B2.3B1.8B1.3B1.2B1.2B
Operating Income126.6M383.2M95.0M(6.5M)(19.9M)(18.9M)
Cost Of Revenue1.2B1.6B1.4B1.1B995.3M901.2M
Income Before Tax70.8M368.5M89.1M(384.4M)(127.6M)(121.3M)
Net Income Applicable To Common Shares59.8M162.1M59.3M(308.1M)(277.3M)(263.4M)
Net Income59.8M162.1M59.3M(308.1M)(148.9M)(141.4M)
Income Tax Expense(5.6M)(1.5M)1.0M(56.5M)(50.8M)(48.3M)
Minority Interest479.5M664.1M(28.7M)19.8M11.9M11.3M
Research Development47.9M61.2M52.4M48.2M40.1M52.2M
Gross Profit329.8M694.7M362.9M221.9M197.6M319.4M
Other Operating Expenses15.5M18.6M12.1M10.6M9.5M15.0M
Net Income From Continuing Ops76.4M369.9M88.0M(327.9M)(160.8M)(152.8M)
Ebit49.6M400.6M95.0M(6.5M)(5.9M)(5.6M)
Total Operating Expenses1.4B1.9B1.7B1.3B1.2B1.2B
Tax Provision(5.6M)(1.5M)1.0M(56.5M)33.2M34.8M
Net Interest Income3.9M(2.9M)(40.5K)2.3M5.1M5.4M
Interest Income7.7M8.7M5.2M6.9M8.7M7.8M
Ebitda122.5M440.6M111.0M(254.9M)(229.4M)(218.0M)
Reconciled Depreciation39.6M55.1M6.0M125.0M95.9M60.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Shenzhen Stock

Shenzhen Glory Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Glory shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).